Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human Integrin alpha V/CD51 Biotinylated Antibody, R&D Systems™

Goat Polyclonal Antibody
Supplier: R&D Systems BAF1219
This item is not returnable.
View return policy
Description
Integrin alpha V/CD51 Polyclonal specifically detects Integrin alpha V/CD51 in Human samples. It is validated for Western Blot, Flow Cytometry, Immunocytochemistry.Specifications
Integrin alpha V/CD51 | |
Polyclonal | |
Biotin | |
NP_002201 | |
ITGAV | |
Chinese hamster ovary cell line CHO-derived recombinant human Integrin alpha V/CD51 Phe31-Val992 Accession # NP_002201 | |
50 μg | |
Primary | |
Detects human Integrin alpha V/CD51 in Western blots. In Western blots, approximately 10% cross-reactivity with recombinant mouse (rm) Integrin alpha V is observed, 5% cross-reactivity with recombinant human (rh) Integrin alpha 2 is observed, and less than 1% cross-reactivity with rhIntegrin alpha 5 and rmIntegrin alpha E is observed. | |
Human | |
IgG |
Western Blot, Flow Cytometry, Immunocytochemistry | |
LYOPH | |
Western Blot 0.1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, Immunocytochemistry 5-15 ug/mL | |
antigen identified by monoclonal L230, CD51, CD51 antigen, integrin alpha-V, integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51), ITGAV, MSK8, Vitronectin Receptor alpha, Vitronectin receptor subunit alpha, VNRA, VNRADKFZp686A08142 | |
Goat | |
Affinity Purified | |
RUO | |
3685 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction